U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498387) titled 'Management of Catatonic Features in Adolescents With Profound Autism' on Feb. 05.
Brief Summary: The goal of this clinical trial is to learn if benzodiazepines and ECT can treat Catatonic features in Adolescents with Autistic spectrum disorder, it will also learn about Safety and efficacy of benzodiazepines and ECT.
the main questions it aim to answer is if adolescents with profound Autism presenting with catatonic features will show significant improvement on treatment with either benzodiazepines or ECT with no major side effects.
it is an open label pilot study whose participants diagnosed with profound autism presenting with c...